BIOGENA • Investment story • Direct digital investment

BIOGENA investment story

A family business becomes a health group. What began for BIOGENA as a family-run micronutrient company is today a health group with more than 120 million euros in revenue.

Since 2015, many investors have accompanied this journey through Invesdor. Since then, BIOGENA has carried out 16 financing rounds via Invesdor. In total, more than 17 million euros in growth capital flowed into the company. BIOGENA is now carrying out a share issue and preparing for a listing on the Direct Market Plus (Vienna MTF) of the Vienna Stock Exchange. This makes BIOGENA an example of direct digital investment in a real company that has developed step by step and is now entering the capital market.

Direct digital investment: the role of Invesdor investors

Between 2015 and 2022, BIOGENA carried out a total of 16 financing rounds via Invesdor. During this period, investors provided more than 17 million euros in growth capital through Invesdor.

This path is characterized by:

1

Long-term partnership

BIOGENA did not choose this form of financing only once, but repeatedly, adapted to each respective growth phase.

2

Direct participation for many instead of a few

Private and smaller professional investors were able to participate at an early stage, with amounts suited to their personal situation. Over the years, this created a broad circle of supporters.

3

Strong European roots

A significant share of the investments came from Germany, Austria and other European countries — the same markets in which BIOGENA is also gaining customers. Since 2015, around 2,100 investors have invested in BIOGENA through Invesdor. On average, investments amounted to around 7,300 euros per person. Depending on the round, the interest rates of the individual bonds ranged from 3.75% to 6.00% per year. All investments were repaid to investors on schedule and in full.

For many people in Germany, Austria and other European countries, BIOGENA therefore offered an opportunity to participate directly in a medium-sized health company and follow its development over several years.

What BIOGENA has achieved so far

The capital market prospectus for the current share issue describes BIOGENA’s starting position with clear figures. For the 2024/2025 financial year, the Biogena Group reports, among other things:

• group revenue of around 124.9 million euros
• historical EBITDA of around 19.1 million euros
• an EBITDA margin of around 15.3 percent
• group equity of around 298.9 million euros

BIOGENA offers more than 400 products and works with around 30,000 doctors and therapists. The company serves customers in around 70 countries and has more than half a million registered members in the BIOGENA Club. According to the prospectus, BIOGENA already has a production capacity built for revenues of around €500 million, which is currently only partially utilized. These figures and structures show an established company with audited financial statements, international reach and a clear focus on prevention and health.

Why the step onto the stock exchange is a logical one

Against this background, the planned step onto the stock exchange is a logical next step for BIOGENA. An IPO enables further equity capital for growth, for example for internationalization, product development, digitalization and new locations.

It creates additional visibility and trust in a regulated environment.

It enables a broader distribution of ownership, into which existing investors can also place themselves as part of their own decisions. For many years, BIOGENA relied on direct financing via Invesdor. This phase helped expand the production capacity, broaden the market and strengthen digital channels. The now planned listing on Direct Market Plus of the Vienna Stock Exchange adds the capital market level to this path.

Context for investors

What investors gain from this now

For people who have already financed BIOGENA through Invesdor, the current development is an important milestone. They can see that a family business has become a health group with revenue well above 120 million euros. All BIOGENA investments placed via Invesdor were repaid as agreed.

• The company has reached a stage where a stock exchange listing can be carried out.

For investors who are only now getting to know BIOGENA, a different perspective emerges: this is a company with a clear market position and tangible products.

• The development of recent years and the current situation are presented transparently in the prospectus.

In both cases, the share issue opens up the opportunity to assess whether and in what form participation in the next stage of the BIOGENA story fits into one’s own investment concept. All information on the current share issue, the use of proceeds and the risks can be found in the capital market prospectus and on BIOGENA’s information page.

Current share issue

Further information on the current BIOGENA share issue

All information on the current share issue, the documents and further details can be found directly on BIOGENA’s information page.

To the BIOGENA share issue

The link opens BIOGENA’s information page in a new tab.

Notes and risks

This text provides information about BIOGENA’s development and the role of Invesdor investors. It does not constitute investment advice and is not an invitation to buy or sell securities. Invesdor does not provide investment brokerage in this context.

The basis for an investment decision is exclusively the published capital market prospectus and the documents of the issuer. Investments in securities and corporate participations involve significant risks, including the complete loss of the capital invested.

The post How Direct Digital Investing can pave the way to the Stock Market first appeared on Invesdor - Blog.

In this interview, Invesdor’s real estate experts — Anna Hoos, Stefan Ertl and Christopher Müller — explain how the market has changed, where new opportunities are emerging, and what investors should pay attention to today.

How do you assess the current development of the real estate market from an investor perspective?

Stefan Ertl: We are coming out of a highly complex market phase that has already had noticeable economic effects, especially within the banking sector. Banks are financing projects much more cautiously today than they did a few years ago and are covering smaller portions of total project costs. At the same time, demand for real estate remains strong across many sectors. This creates a financing gap, as project developers now need to provide more equity to move projects forward.

What developments are currently shaping the real estate market?

Christopher Müller: The real estate market moves in cycles — and we are currently in one of those cycles. However, the current downturn and adjustment phase has been accelerated by an exceptional combination of external shocks: COVID-19, the war in Ukraine, the energy crisis, inflation, and rising interest rates all impacted the market within a short period of time. Even so, the overall market behavior still reflects patterns we know from traditional real estate cycles.

What makes this phase different is the structural transformation emerging from it. Higher financing costs, persistently elevated construction costs, increasing regulatory requirements, and growing political pressure around housing are leading to a new market equilibrium. The market that emerges from this period will look fundamentally different from the one before the crisis.

At the same time, housing remains one of the most urgent topics. Demand for residential space continues to significantly exceed supply. In Germany alone, the government is currently missing its annual target of 400,000 new homes by approximately 100,000 to 150,000 units, while a broader housing shortage of more than one million homes is being discussed. Housing and infrastructure therefore remain structural pillars within a market that is currently repositioning itself.

The post Real Estate as an Investment: Is Now the Right Time to Get Started? first appeared on Invesdor - Blog.

In this interview, Invesdor’s real estate experts, Anna Hoos, Stefan Ertl, and Christopher Müller, explain how the market has changed, which opportunities are emerging, and what investors should pay attention to today.

The Real Estate Team at Invesdor: Stefan Ertl, Anna Hoos, and Christopher Müller.

How do the experts assess the current development of the real estate market from an investor’s perspective?

Stefan Ertl: We are coming out of a highly complex market period that has already had noticeable economic consequences, especially within the banking sector. Today, banks finance projects far more cautiously than they did a few years ago and cover smaller portions of projects. At the same time, demand for real estate remains strong across many sectors. As a result, a financing gap has emerged because developers now require more equity to realize projects.

Which developments are currently shaping the real estate market?

Christopher Müller: The real estate market moves in classic cycles, and we are currently in one of those cycles. However, the current downturn and adjustment phase has been accelerated by an exceptional combination of external shocks: COVID-19, the war in Ukraine, the energy crisis, inflation, and rising interest rates have all heavily impacted the market within a short period of time. Nevertheless, this phase still shows many characteristics of traditional real estate cycles.

What makes this phase unique is the structural transformation emerging from it. Higher financing costs, persistently high construction costs, stricter regulations, and growing political pressure around housing are creating a new market equilibrium. The market emerging from this situation will be fundamentally different from the one before the crisis.

At the same time, housing remains one of the most urgent issues. Demand for residential space still significantly exceeds supply. In Germany alone, the government is currently missing its annual target of 400,000 new homes by approximately 100,000 to 150,000 units, while discussions continue around a housing shortage exceeding one million homes. Housing and infrastructure therefore remain structural pillars in a market that is currently repositioning itself.

What role does Invesdor currently play in the real estate market?

Christopher Müller: Invesdor originally comes from corporate financing and has continuously evolved over the past years. Today, our offering aligns precisely with current market needs: we enable real estate projects that, under today’s conditions, are often no longer feasible through bank financing alone. As a flexible capital component, we complement traditional bank financing, allowing developers to realize their projects and optimize their return on equity. Our goal is to provide innovative developers with modern, digitally organized capital, and in doing so, help create new housing and future-proof real estate projects.

Why are real estate projects an important part of Invesdor’s offering?

Stefan Ertl: After successfully building our renewable energy division, expanding into real estate was the logical next step for us. The first development projects on our platform were funded very quickly by investors. That clearly shows there is strong demand for this type of investment. For us, real estate is not a side activity but a central pillar of our offering. We can provide investors with predictable returns directly linked to tangible assets while simultaneously financing projects that create new housing and contribute to climate and sustainability goals within the built environment.

Which areas of the real estate market currently show the greatest potential according to the experts?

Christopher Müller: We do not limit ourselves to one specific segment, but instead focus carefully on where opportunities and solid concepts emerge under current market conditions. In recent years, we have gained particularly strong experience with sustainable logistics and industrial real estate projects. In addition, we see significant future potential in converting office space into residential housing: while office vacancies are increasing in many areas, there is simultaneously a shortage of affordable housing — especially in cities. This is precisely where intelligent project development and suitable financing solutions can create real added value for tenants, owners, and investors alike.

What is the difference between investing through the Invesdor platform and buying real estate directly?

Anna Hoos: With an investment through our platform, investors do not purchase property themselves, but instead participate as capital providers in the financing of a specific project, with a fixed interest rate and a clearly defined term. Unlike a traditional real estate purchase, investors do not have to deal with selection, acquisition, management, or leasing; these responsibilities remain entirely with the project developer.

What advantages does this type of real estate investment offer compared to direct ownership?

Christopher Müller: When purchasing real estate directly, capital is concentrated in a single property and all associated obligations come with it: from additional costs and maintenance to rental management. With an investment through Invesdor, investors instead participate only in the financing phase of a project. This allows smaller amounts to be diversified across multiple real estate projects without involvement in operational management.

How does Invesdor approach the topic of risk?

Anna Hoos: Every investment fundamentally involves risks. Our goal is to present these risks as transparently as possible and, where meaningful and feasible, mitigate them through appropriate structures. Nevertheless, crowdinvesting remains an entrepreneurial investment with subordinated risk and the possibility of total loss.

How does Invesdor select the projects that appear on the platform?

Anna Hoos: We present projects on the platform whose concepts appear plausible and understandable under current market conditions, particularly regarding location, usage, financing, and planning. We place strong emphasis on transparency so investors can make well-informed independent decisions.

Real estate as an investment: why can it be a valuable addition to a portfolio?

Christopher Müller: Real estate financing can be a meaningful addition to a portfolio because it is ultimately backed by a tangible asset. Through our platform, investors participate in clearly defined project phases with fixed interest rates and transparent terms, typically ranging from one to three years.

What should investors pay particular attention to?

Stefan Ertl: It is important to fully understand the project as a whole: what exactly is being built or developed, and at what stage is the project currently? Investors should also carefully review the developer’s track record and the transparency of the financing structure.

The post Real Estate Investing in 2026: Opportunities & Risks first appeared on Invesdor - Blog.

In recent years, some of the most significant value creations in global markets have happened before companies even reached the public stock exchange. Investors who gained early access to companies like Airbnb, Uber, or Snowflake often saw substantial valuation increases between late-stage private rounds and their eventual IPOs.

For example, Airbnb was valued at around $31 billion in private markets in 2017 and reached a market capitalisation of over $100 billion shortly after its IPO. Similarly, Snowflake became one of the largest software IPOs ever, delivering strong valuation uplifts from its final private funding rounds.

More recently, companies like OpenAI, Anthropic, and Oura have shown how quickly valuations in late-stage private markets can evolve – driven by technological breakthroughs, rapid adoption, and global market positioning.

At the same time, access to these opportunities has traditionally been limited to institutional investors, venture capital funds, and ultra-high-net-worth individuals.

Why is Invesdor offering Pre-IPO investments?

At Invesdor, we believe investors should be able to build diversified portfolios across the full company lifecycle. Invesdor already provides access to growth-stage startups and scale-ups through equity funding, as well as to more mature SMEs, renewable energy and real-estate investment opportunities via fixed-interest debt. Between these, there has traditionally been a gap.

Pre-IPO investments are designed to close this gap by offering investors access to late-stage companies that are already well-developed and often have a clear path toward an IPO or strategic exit within a few years.

The goal is to enable investors to participate in value creation from early growth all the way to the pre-IPO stage, while being transparent that these investments remain illiquid, high-risk, and should be considered as part of a diversified portfolio.

We are an impact-first investment platform. At the same time, we believe in expanding access to a broader range of opportunities, including pre-IPO investments. While the companies we currently have visibility on are not primarily impact- or ESG-focused, we will continue to monitor this space and aim to include more impact-aligned opportunities over time.

What is Pre-IPO investing? An introduction

Investing in companies before they go public has traditionally been reserved for institutional investors, venture capital funds, and ultra-high-net-worth individuals. However, access to these opportunities has gradually broadened, allowing a wider range of investors to participate in what is known as Pre-IPO investing.

In this article, we explain what Pre-IPO investing is, how it works in practice, and what investors should carefully consider before deciding to invest.

What does “Pre-IPO” mean?

A Pre-IPO investment refers to investing in a company while it is still privately held – meaning before its shares are listed and traded on a public stock exchange.

At this stage, companies are typically relatively mature. They often generate substantial revenue, have established business models, and are backed by experienced investors. In many cases, such companies are preparing for a potential exit such as an IPO or a strategic sale.

Typical characteristics of Pre-IPO companies include:

• A proven product or service with growing market traction
• Strong revenue growth and scaling operations
• Institutional investors already on the cap table
• A potential path toward an IPO or acquisition

These companies are often active in sectors driven by long-term trends such as technology, energy transition, or digital infrastructure, making them particularly relevant for forward-looking investors.

Why do investors consider Pre-IPO companies?

Investing in Pre-IPO companies can offer access to companies at a stage where significant growth potential still exists, while the business is already more developed than in early-stage venture investing.

Investors are typically attracted by a combination of strategic and financial considerations:

• Early access to growth – Invest in the potential return of a company before it enters public markets
• Potential valuation upside – Opportunity to benefit from future price increase at IPO or exit
• Diversification – Exposure to private markets alongside listed assets
• Innovation exposure – Access to some of the most innovative companies globally

At the same time, it is important to recognise that Pre-IPO investment opportunities are not directly comparable to listed equities. The expected investment horizon is longer and the risk associated with the investment product is higher.

How does Pre-IPO investing work in practice?

Unlike investing in publicly listed shares, Pre-IPO investments are usually structured indirectly through so-called derivatives, as direct access to company shares is often restricted.

In practice, the structure often works as follows:

• Investors subscribe to a financial instrument (e.g. a bond or participation structure)
• The financial instrument is constructed to follow the return of the target company
• The invested capital is pooled and deployed via special purpose vehicles (SPVs)
• These SPVs acquire shares in the target company
• Investors get financial exposure towards the performance of the target company

This means that investors do not hold shares in the target company directly but gain exposure to the return of the target company through a structured setup. While this structure enables access, it also comes with additional layers that need to be understood, including legal structure, fees, and governance.

Typical exit scenarios for Pre-IPO investments

Pre-IPO investments are by default long-term investments, where the return depends on a successful future exit event. The exit may be significantly delayed, occur later than anticipated, or not happen at all.

The most common exit routes include:

• Initial Public Offering (IPO) – The target company lists its shares on a stock exchange
• Mergers and Acquisitions (M&A) – The target company is acquired by another firm
• Secondary transactions – The shares of the target company are sold to other private investors

It is important to highlight that the timing and likelihood of an exit is uncertain. Even if a company has communicated IPO ambitions, market conditions or strategic decisions can delay or prevent such an outcome. In addition, lock-up periods after an IPO may restrict immediate liquidity.

Pre-IPO investments: understanding the key risks

Investing in Pre-IPO companies is associated with a higher level of risk compared to traditional listed equities, and a clear understanding of these risks is essential.

Key risk factors include:

• Total loss risk – The invested capital can be lost entirely
• Illiquidity – Capital is typically tied up for several years
• Structural complexity – Indirect investment structures add additional layers
• Valuation uncertainty – Private market pricing can change significantly
• External influences – Market conditions, regulation, and macroeconomic factors impact outcomes

In addition, investors should consider that fees, dilution effects, and currency fluctuations may further influence the final return and potentially reduce performance.

Pre-IPO investments in a portfolio: how to position them effectively

Investments in Pre-IPO companies can play a valuable role within a diversified portfolio, particularly for investors seeking exposure to innovation and long-term growth trends.

However, Pre-IPO companies should be positioned carefully. In most cases, such investments are best understood as:

• A complementary allocation to traditional investments such as listed equities or bonds
• A long-term investment with limited liquidity
• An opportunity-driven exposure where the expected risk and return is higher than in traditional investment products

Diversification across assets and a clear understanding of the individual target companies is essential.

New investment opportunities: access for retail investors

By offering investors access to invest in Pre-IPO companies, Invesdor gives retail investors access to a part of the market that has historically been available only to professional investors. This allows investors to participate in the potential return of some of the most innovative companies globally before they enter public markets and become available to the public.

At the same time, this access comes with increased complexity and risk. Understanding the structure, evaluating the underlying company, and taking a long-term view on the investment are all critical elements of a sound investment decision.

As with any investment, one principle remains unchanged:

Higher potential returns are always accompanied by higher risks, and building a diversified portfolio is key for sustainable success.

The post Pre-IPO Investing first appeared on Invesdor - Blog.

Energy is the silent engine behind everything we do. It powers every lit home, every operating factory, and every moving train. Most of the time, we barely think about it, until shortages occur. Then energy bills double overnight, companies scale back production, and countries exert pressure through control of supply.

Today, energy is no longer just an economic resource. It has become a strategic asset. This is why investing in sustainable energy in Europe is becoming increasingly relevant for both policymakers and investors.

Energy Security and Geopolitics: A System Under Pressure

Experts in energy, security, and geopolitics increasingly agree that Europe must accelerate the transition to sustainable energy. Not only to meet climate targets, but also to strengthen security and economic resilience. That urgency is reflected in European policy as well. Through REPowerEU, the European Commission has made clear that reducing dependence on imported fossil fuels is essential to Europe’s long-term stability and resilience.

This shift in thinking is driven by a simple reality: Europe’s energy system remains vulnerable to external shocks. As global power relations become more unstable, energy can no longer be seen as a neutral commodity. It is deeply tied to security, sovereignty, and strategic autonomy.

That vulnerability becomes especially visible in times of geopolitical tension. Disruptions in key transport routes, such as the Strait of Hormuz, can trigger immediate uncertainty across European energy markets. When global supply is threatened, energy prices react quickly. Gas prices on major European exchanges have jumped from around €30–40 to €70 per MWh in short periods of tension, while oil prices have risen from roughly $70–80 to nearly $120 per barrel. Those movements are not abstract market events. They affect households, businesses, and entire economies across the continent.

But the issue goes beyond price volatility. At its core, it is about trust. When energy supply becomes uncertain, the stability of societies begins to feel less secure as well.

Europe’s Energy Dependency

Europe’s challenge is not only short-term volatility, but also structural dependence. The European Union still imports more than half of its energy, which leaves the continent exposed to decisions made elsewhere: by producing countries, international markets, and political actors far beyond Europe’s control.

That dependency creates several layers of risk. It increases exposure to price swings, raises the likelihood of supply disruptions, and leaves room for political pressure through energy exports. In recent years, European policymakers and analysts have repeatedly warned that the most serious threats are not always dramatic or visible. In some cases, pressure comes through more subtle forms of disruption and manipulation that are difficult to prove, yet still capable of causing significant damage.

The conclusion is clear. As long as Europe remains heavily dependent on external energy sources, it remains vulnerable.

A Transition Driven by Necessity

At the same time, this vulnerability is accelerating change. What was once primarily a climate ambition is now also an economic and strategic necessity.

Rising energy prices and geopolitical uncertainty are making investments in renewable energy, storage, and efficiency more attractive. A system based on locally generated energy is not only more sustainable, but also more resilient.

This is why the European energy transition is gaining momentum. Through initiatives like REPowerEU, the focus is on expanding renewable capacity, strengthening infrastructure, and reducing reliance on imported fossil fuels. The direction is clear, the pace is increasing.

Projects Supporting Europe’s Energy Transition

The energy transition is built through concrete projects that strengthen the system in different ways.

BESS Wehr — Battery Storage

As Europe adds more solar and wind power, storage becomes essential. BESS Wehr helps absorb peaks in supply and release electricity when production drops, making the grid more flexible and less dependent on fossil backup. In doing so, it supports grid stability at a time when balancing renewable energy is becoming increasingly important.

Fountain Fuel — Hydrogen Infrastructure

Not every sector can be electrified easily. Fountain Fuel supports heavy transport with hydrogen infrastructure, helping reduce fossil fuel dependence in one of the harder sectors to decarbonize. That makes hydrogen an important complement to electrification in the broader energy transition.

Rainmaker — Renewable Water Solutions

Rainmaker shows how renewable energy can also strengthen water security. By producing water from air and purifying larger volumes, it contributes to infrastructure resilience more broadly, linking clean energy to resource security in a practical way.

Der Solarteur — Sustainable Buildings

Because buildings account for a large share of energy demand, improving them is essential to the transition. Der Solarteur helps reduce fossil energy use through solar panels, heat pumps, and battery systems, making homes and commercial buildings more energy-efficient and less dependent on external energy sources.

Together, these projects show that the transition is not driven by one single technology, but by a combination of storage, hydrogen, resource efficiency, and cleaner buildings.

Investing in Europe’s Energy Future

For investors, this transformation creates a clear opportunity. Investing in sustainable energy in Europe is no longer a niche, but one of the continent’s most important and fast-growing investment themes.

Through platforms like Invesdor, investors can participate directly in this transition by financing concrete projects. Instead of investing in abstract funds, they gain exposure to tangible initiatives with measurable impact.

At the same time, these investments often offer stable, fixed returns, alongside diversification across technologies and markets. Combined with strong policy support and growing demand, this makes sustainable energy increasingly attractive from both a financial and strategic perspective.

A Strategic Turning Point for Europe

Europe is entering a new energy era. Dependency on external sources has become a structural risk, while sustainable energy has become part of the solution.

Investing in sustainable energy is therefore not only about supporting the climate transition. It is about contributing to a more stable, independent, and resilient Europe. As a result, investing in renewable energy in Europe is driven not only by sustainability goals, but also by the need for long-term stability and independence.

For investors, it offers a way to combine impact with return, and to be part of a transformation that is already reshaping the continent.

The question is not whether the energy transition will happen, but who is already helping to build it.

Frequently Asked Questions

Why is investing in sustainable energy in Europe important?
Because it reduces dependence on imported fossil fuels, strengthens energy security, and supports a more stable and resilient European economy.

How does geopolitics affect Europe’s energy market?
Geopolitical tensions can disrupt supply routes, drive up energy prices, and increase the risk of political pressure through energy exports.

What is energy security?
Energy security refers to having a reliable, affordable, and stable energy supply that is less vulnerable to external shocks.

Why is Europe accelerating the energy transition?
Due to a combination of climate goals, rising energy costs, and the need to reduce reliance on external suppliers.

What role do technologies like battery storage and hydrogen play?
Battery storage helps stabilise renewable energy supply, while hydrogen offers a solution for sectors that are difficult to electrify, such as heavy transport.

Is investing in renewable energy profitable?
Many renewable energy projects offer stable, predictable returns and benefit from long-term policy support and growing demand.

Sources & References

• European Commission. REPowerEU Plan: Joint European Action for More Affordable, Secure and Sustainable Energy
  https://commission.europa.eu/topics/energy/repowereu_en
• International Energy Agency. World Energy Outlook & Electricity Market Reports
  https://www.iea.org
• Eurostat. Energy Import Dependency Statistics
  https://ec.europa.eu/eurostat
• DNV. Energy Market Analysis and Energy Transition Outlook
  https://www.dnv.com
• European Council. Energy Security and EU Policy Conclusions
  https://www.consilium.europa.eu
• Solar Magazine (2026). Iran conflict triggers one of the largest fossil energy shocks in decades
  https://solarmagazine.nl
• NU.nl (2026). Faster sustainability increases resilience against conflict
  https://www.nu.nl

The post Why Investing in Sustainable Energy Is More Relevant Than Ever first appeared on Invesdor - Blog.

How do investments in healthcare help close gaps in care while also generating returns?  MedTech and healthcare investments are among the most stable and at the same time most innovative segments of the global healthcare market.   

MedTech and healthcare investments refer to capital allocated to companies that develop and commercialize medical technologies, digital health solutions, or healthcare infrastructure.

While many markets are subject to strong fluctuations, the demand for medical and healthcare services remains constant. It continues to grow with an aging population, increasing life expectancy  (according to the Deloitte Global Health Care Outlook 2025 the number of people over 65 in Europe will increase by around 30% by 2030) and the rising prevalence of chronic diseases such as diabetes and cardiovascular conditions.  

This demographic shift increases the pressure on healthcare systems and raises demand for efficient, technology-driven solutions.  

At the same time, healthcare systems are reaching their limits: hospitals are struggling with overload, waiting times are increasing, and modern diagnostics are not available to everyone. This is where new business models and medical technologies come into play. They create access where gaps previously existed and improve processes that have so far been inefficient.

For investors, this creates unique opportunities: MedTech and healthcare investments at Invesdor combine social impact with attractive return potential. Investors support concrete solutions with measurable impact.

Through Invesdor, investors gain access to MedTech and healthcare companies that have already overcome key hurdles and are preparing for the next stage of scaling. These projects combine societal impact with financial prospects. They are also aligned with the United Nations Sustainable Development Goals (SDGs).

MedTech & Healthcare Investments at a Glance  

MedTech and healthcare investments involve companies that improve medical care while building on robust business models.

In Europe, more than 90% of the MedTech sector consists of small and medium-sized enterprises (SMEs). This structure opens attractive opportunities for investors to enter early. At the same time, it requires a solid understanding of development stages, as smaller providers are more dependent on regulatory processes and scaling dynamics.

Germany, Switzerland, and the Netherlands are among the world’s most innovative locations.
Many companies here have overcome significant challenges: they are CE-certified, have completed clinical trials, or have generated their first revenue.  

Challenges and opportunities for Europe’s MedTech market   

According to the industry report   MedTech Europe Facts & Figures and MedTech Europe Facts & Figures 2024 the European medical technology market has been growing steadily at around 5% per year for several years.
 
Unlike traditional early-stage startups, many companies in this sector have already overcome key challenges: they are CE-certified, have completed clinical trials, or have generated initial revenues.  

For investors, this means they typically enter after this phase while still benefiting from significant scaling potential.

Typical segments include:  

• MedTech: devices, implants, and digital tools for diagnostics and therapy  
• Healthcare infrastructure: for example modern diagnostic systems and equipment fleets that hospitals can use and finance flexibly
• Digital Health:  telemedicine, platforms, and wearables 
  
  

Good to know: MedTech

• There are around 38,000 MedTech companies in Europe, about 90% of which are small and medium-sized enterprises (SMEs).
  
• The MedTech sector is one of the most innovative industrial sectors,  accounting for 
  about 8% of all industrial patent applications in Europe. 
  
• MedTech contributes significantly to the economy in terms of employment, exports, and innovation. The European MedTech industry directly employs more than 930,000 people. 
  
• The European MedTech market is estimated at around €170 billion for 2024, representing 
  about 26.4% of the global market. 

(Sources: MedTech Europe Employment & Companies , MedTech Europa Market , MedTech Europe Facts & Figures)  )

Health, innovation, and sustainability: Why Invesdor focuses on MedTech and Healthcare Investments 

According to an analysis by Deloitte („Europe’s MedTech Attractiveness“, 2025, Europe’s MedTech Report 2024) Europe is one of the most attractive regions for MedTech investments. In addition to a strong regulatory framework and excellent research, well-connected innovation clusters form the backbone of the European healthcare market.  

These innovation clusters include in particular the Nordic countries. Finland has developed into a leading location for MedTech start-ups. You can learn what enables this success in the article „8 Reasons for the Success of Finnish MedTech Companies“  

Health as a Growth Engine of the European Economy  

The EFPIA report “The Case for Investing in a Healthier Future for the European Union” also shows that every euro invested in the healthcare sector leads to higher quality of life, lower disease costs, and a more resilient economy in the long term. EFPIA concludes that health should be viewed not merely as a cost factor but as a driver of economic growth.

The European MedTech sector is strongly export-oriented. According to MedTech Europe 2024, around 60% of global medical technology exports originate from Europe. For investors, this means stable international demand, currency diversification, and growth beyond national markets.

Sustainability and Regulation Are Becoming More Important 

Invesdor views health as a central pillar of sustainable investments. Medical innovation directly improves the lives of millions of people while creating scalable business models. Every funding request is reviewed before being listed on our platform. The connection to the UN Sustainable Development Goals (SDGs) plays an important role. Depending on the project, the following goals are particularly relevant:

Good Health and Well-being (SDG 3)

MedTech and healthcare projects improve patient care. Modern diagnostics, digital systems, and new therapies enable earlier treatment and increase the chances of recovery. Every investment in this field directly contributes to improving health and quality of life.

Gender Equality (SDG 5)

Many MedTech and healthcare projects specifically address the needs of women in healthcare. From innovations in neonatology to technologies for female-specific diseases, solutions are emerging in areas that have long been neglected. Investments in such projects strengthen gender equality in healthcare and improve care for female patients.

Affordable and Clean Energy (SDG 7)

Energy efficiency also plays a role in healthcare. Modern devices and digital systems are increasingly designed to consume less electricity and to function reliably even in regions with unstable energy supply. For investors, this means supporting companies that use sustainable technologies while reducing costs for hospitals and patients.

Industry, Innovation and Infrastructure (SDG 9)

Healthcare investments promote modern technologies and the expansion of medical infrastructure. This includes robotic support systems, digital platforms, and flexible diagnostic solutions. Investors support companies that transform research innovations into market-ready products.

Reduced Inequalities (SDG 10)

Many healthcare projects make high-quality care accessible to more people. Pay-per-use models or mobile devices help hospitals in regions with weaker infrastructure. Investments therefore contribute to greater equality in healthcare systems.

Responsible Consumption and Production (SDG 12)

More and more companies are developing MedTech solutions that are resource-efficient and durable. They rely on reusable components and efficient production processes. Investors thus promote both medical impact and responsible resource management.

Partnerships for the Goals (SDG 17)

Progress in healthcare emerges through collaboration. Start-ups, hospitals, universities, and investors work together to bring innovations to market faster. Every investment strengthens this network and amplifies the impact of medical advancements.

We select projects that meet SDG standards. This ensures that investors support robust business models while contributing to solutions that promote ecological, social, and economic sustainability in healthcare. 

Challenges and Opportunities for Sustainable Investments in MedTech and Healthcare 

The healthcare and MedTech sector is considered one of the most exciting areas for investors—stable, innovative, and with clear societal relevance. At the same time, it is complex: regulations, clinical trials, and technological developments determine the pace and involve elevated risks. Investors should understand these mechanisms and be prepared for longer timelines. With foresight, real and sustainable value can emerge.

From Research to Practice: Examples of Successful MedTech Investments

The following examples illustrate different areas of modern MedTech investments. They range from highly specialized diagnostics to digital platform solutions and practical medical aids for everyday life. Each project addresses a clear clinical need, relies on scalable technology, and combines measurable healthcare impact with a sustainable business model. This highlights what matters to investors: evidence-based solutions, transparent milestones, and a clear path to scaling.

Megin: precise brain diagnostics with MEG technology, used worldwide

Megin is a Finnish MedTech company specializing in magnetoencephalography (MEG). This technology measures the magnetic fields generated by electrical signals in the brain, enabling physicians to analyze brain activity in real time.

This is particularly helpful for complex neurological conditions such as epilepsy or brain tumors. More precise diagnostics simplify the planning of surgeries and therapies.

Megin was founded in 1989 and is headquartered in Helsinki. The company is one of the global leaders in MEG technology. More than 120 systems are already installed in hospitals and research institutions. According to the company, it holds over 80% market share in new MEG system installations.

Clinical need and solution: precise mapping of brain function

Neurological diseases often present medicine with a precision challenge. For many procedures, it is crucial to accurately locate specific brain regions. 

Megin’s TRIUX Neo system measures the weak magnetic fields produced by neuronal activity. This allows functional brain areas to be visualized with extremely high temporal and spatial resolution. The method is non-invasive and does not involve radiation exposure. 

This information helps physicians plan procedures more precisely and reduce risks. 

Technology and status: established solution in a specialized market

Megin is considered an established provider in a technically demanding segment of medical technology. Its systems are used worldwide in hospitals and research institutions. Patents, specialized technical expertise, and regulatory requirements create barriers to entry for new competitors. At the same time, demand for precise brain diagnostics is increasing as neurological diseases rise globally.

Impact: better diagnostics and more targeted treatments

When physicians can localize brain functions more precisely, surgeries and therapies can be planned more effectively. This helps reduce risks and improve treatment outcomes. This aligns with the sustainability goal SDG 3 “Good Health and Well-being.” Advances in neurological diagnostics contribute to improving patient care in the long term.

Investor benefit: fixed-interest bond with clear terms

The company was financed through a bond. The terms are clearly structured:  

The financing round reached more than €3.5 million and was supported by more than 1,200 investors.

Megin generates revenue through the sale of MEG systems and service contracts for maintenance and operation. These service contracts provide recurring revenue.

Risks and management: investment cycles and regulatory requirements

The market for highly specialized medical technology is characterized by investment cycles. Hospitals often make large equipment decisions on a long-term and project-based basis. In addition, the installation of an MEG system requires specialized infrastructure such as magnetically shielded rooms. Regulatory requirements and production processes also shape the industry. Megin addresses these challenges through decades of industry experience, an installed system base, and international customer relationships.

Megin illustrates how specialized medical technology can combine investment opportunities with medical progress. Hospitals gain access to precise brain diagnostics while investors participate through a structured bond in the further development of this technology.

Pirche: AI-powered platform making organ transplantation more predictable

Pirche develops a digital diagnostics platform for transplant centers and clinical laboratories. After an organ transplant, immunological compatibility often determines how long a transplanted organ remains functional. Pirche focuses precisely on this point. The platform combines genetic typing with AI-driven modeling and supports physicians in identifying risks earlier and managing therapies more precisely.  

The need is significant. Many transplanted organs lose function within five to ten years. For patients, this means additional procedures, intensive treatments, and increased health burdens. Any improvement in donor organ matching and post-transplant care can therefore make a meaningful difference.

Clinical need and solution: better matching and more targeted follow-up care 

In transplant medicine, laboratories and medical teams already compare key parameters such as blood type and HLA markers. However, this information is not always sufficient to reliably estimate long-term risks. Pirche expands this analysis with additional immunological models.

The platform creates individualized immune risk profiles and supports clinical decision-making with advanced analyses. It uses data that is already available in many clinical laboratories, allowing the technology to integrate into existing workflows without requiring additional data collection.

Technology and status: patent-protected, scientifically documented, integrated into hospital IT

Pirche combines genetic typing with AI-based analysis to visualize complex interactions between donor and recipient. The underlying algorithms are protected by patents and have been examined in numerous scientific publications.

The platform has already been used in a large number of patient cases and further developed in collaboration with international hospitals and research institutions. Partnerships with laboratory providers such as Thermo Fisher Scientific and Werfen-Immucor facilitate integration into existing hospital IT systems.  

Impact: better treatment outcomes and more efficient resource use

When risks are identified earlier, follow-up care and immunosuppression can be adjusted more precisely. This can help reduce complications and extend the functional lifespan of transplanted organs. Such progress contributes to SDG 3 “Good Health and Well-being.”

Responsible use of medical resources also plays a role. Donor organs are extremely scarce. More precise matching can help extend their usability and avoid repeated procedures.

In addition, the analysis considers specific risk groups in transplant medicine, such as highly sensitized patients. This can help reduce inequalities in healthcare access.

Investor benefit: participation in a scalable B2B SaaS platform

The financing took place through an equity investment (security). The price per share was €15.85, with a minimum investment of 20 shares. Between 1.07% and 5.15% equity was offered at a pre-money valuation of approximately €36.86 million. In total, 578 investors participated.

The business model is based on software-as-a-service contracts with transplant centers and clinical laboratories. Hospitals access the platform through subscriptions, while partnerships with laboratory service providers enable further integration opportunities. Such models can generate recurring revenue when software becomes permanently integrated into clinical workflows.

The investor base includes experienced entrepreneurs and investors from the healthcare industry, including individuals with backgrounds in biotechnology. These investors contribute not only capital but also industry expertise and networks.

Risks and management: clinical adoption, regulation, and market dynamics

Digital diagnostics in clinical practice requires trust, strong evidence, and seamless integration. Pirche addresses these requirements through scientific documentation, a large number of evaluated cases, and IT partnerships. Nevertheless, the speed at which hospitals adopt new decision-support software into processes and budgets remains a key factor.

Regulatory requirements for healthcare software, particularly AI-based systems, also shape development. Pirche focuses strongly on the US transplant market, which offers opportunities but also introduces certain dependencies.

Pirche demonstrates how digital diagnostics can create value in a highly critical medical field. Hospitals gain a platform for improved risk management, patients may benefit from more stable outcomes, and investors participate in a patent-protected B2B SaaS model with documented usage and a clear commercialization strategy.

STIL: Steady Hands for an Independent Life

STIL  develops an orthosis that stabilizes the hands. A cup of coffee remains steady. A pen produces a readable signature again. A shirt button can be fastened without help. This is exactly where the STIL orthosis helps. It sits lightly on the forearm, specifically dampens tremors, and works immediately. Clinical data shows tremor reduction of more than 80 percent. Users regain control, can perform everyday tasks independently, and feel more confident.

Since 2023, STIL has been in use—first in the Netherlands and now also in Germany, Belgium, and Italy. Medical supply stores and orthopedic partners fit the orthosis and support users, bringing the solution directly into daily life.

Clinical need and solution: effective, practical, immediately available

Tremors significantly limit everyday life. Eating, writing, or dressing becomes difficult. Shame often leads to social withdrawal.

The STIL orthosis mechanically stabilizes the arm. It dampens uncontrolled movements without restricting natural motion. The effect is immediate. No electricity is required. The orthosis is easy to put on and adjust, even at older ages. Medical supply providers and orthopedic specialists support patients locally.

Technology and status: certification and clinical data

The STIL orthosis is CE-certified and FDA-registered. STIL operates under ISO 13485. A clinical study demonstrates its effectiveness for essential tremor, while additional studies are expanding its application to Parkinson’s disease and other movement disorders. The modular design adapts to different sizes and needs. Distribution partners in the Netherlands, Germany, Belgium, and Italy expand market reach. A new AI-based app supports screening and simplifies initial assessments for patients and distributors.

Impact: more independence, lower costs, stronger participation

Reduced tremors allow people to eat, write, and work independently again. This strengthens dignity and participation. Hospitals and insurers benefit from a non-invasive alternative to surgery or long-term medication. The orthosis helps reduce follow-up costs and relieve healthcare systems. It contributes to SDG 3 and, through durable and repairable product design, also supports SDG 9 (Industry, Innovation and Infrastructure), SDG 10 (Reduced Inequalities), and SDG 12 (Responsible Consumption and Production).

Investor benefit: validated technology, rapid distribution, large market

STIL combines medical benefit with a clear go-to-market strategy. Distribution runs through an established network of medical supply stores and orthopedic partners, including Ottobock (Italy), STOLLE (Germany), and VIGO (Belgium). The addressable market in the EU and the US is worth billions. Renowned investors such as Health Innovations, Rabobank, the EIC Accelerator, and the Brain Foundation Netherlands support growth. The latest valuation was €10 million pre-money. The round offered strengthened shareholder rights for new investors and followed a clear exit logic.

Risks and management: reimbursement, adoption, scaling, regulation

Reimbursement pathways vary by market. STIL works with pilot centers, key opinion leaders, and partners to secure coverage. Adoption in daily practice is supported by training, simple fitting processes, and distributor support. Scaling and supply chains are planned step by step with clear quality processes. CE certification, FDA registration, and ongoing studies reduce regulatory uncertainty. The AI screening app improves matching and increases success rates in patient care.

STIL brings a clinically validated, non-invasive solution into standard care. Patients gain independence in daily life. Healthcare providers operate more efficiently. Investors gain access to a scalable MedTech company with a clear distribution strategy, growing partnerships, and strong validation.

Healthcare investments: benefits for people and investors

Investments in MedTech and healthcare combine economic stability with social impact. They allow investors to actively contribute to improving medical care while achieving attractive long-term returns.

MedTech and healthcare projects are a valuable addition to a diversified portfolio. They respond to global megatrends such as demographic change, technological innovation, and the growing demand for efficient healthcare.

For Invesdor, it makes sense to focus on companies that:

develop new medical technologies that improve diagnostics, therapy, or care,
optimize existing systems by digitizing processes or making devices more sustainable, 
expand medical infrastructure, for example through pay-per-use models or mobile solutions,  
scale internationally to bring innovations to new markets more quickly.  

Such projects meet clear sustainability and quality standards and offer strong value creation potential.

The healthcare sector is considered particularly resilient: people require medical services regardless of economic cycles. Healthcare investments therefore offer long-term stability. Companies with CE certifications and validated clinical data increasingly meet strict regulatory requirements, which further strengthens their market position.

MedTech and healthcare offer growth potential through scaling, market expansion into new regions, and possible exits to larger corporations. Investors benefit from the combination of measurable impact, innovation dynamics, and predictable return models—whether through bonds with fixed interest or equity investments with upside potential.

As with any asset class, risks exist. In the MedTech sector, these include potential delays in studies, regulatory changes, or longer approval processes. Liquidity challenges or dilution in follow-up financing rounds can also influence return profiles. Equity investments also carry the risk of partial or total loss.

A structured due diligence process such as the one applied by Invesdor helps reduce these risks.

Projects are evaluated based on financial metrics, clinical evidence, ESG criteria, and sustainability standards. This provides investors with access to vetted, viable, and impact-oriented companies.

An investment in the healthcare sector allows investors to influence the future of medical care. Those who invest in MedTech and healthcare contribute to accelerating innovation, improving patient access to treatment, and strengthening healthcare systems worldwide—while combining this social contribution with a clear economic perspective.

God to know:  How Invesdor selects Healthcare and MedTech projects 

Invesdor reviews every project through multiple stages to ensure quality, transparency, and sustainability:

Only about 5% of submitted projects make it onto the Invesdor platform. Further details about the evaluation process for investment opportunities can be found here: Investment Evaluation Process.

Invest in health now: your chance to actively shape the future! 

Healthcare and MedTech investments combine financial stability with social impact. Investors support innovations that improve lives—from advanced diagnostics and digital health solutions to new medical technologies. At the same time, they benefit from a growth market that is largely independent of economic cycles.

Those who invest in this sector promote progress, improve access to better care, and actively shape the future of medicine.

Discover current investment opportunities on Invesdor:
projects that combine medical progress with economic potential.

Start today and invest in a healthier future! 

The post MedTech and Healthcare Investments: Opportunities, Risks, and Examples first appeared on Invesdor - Blog.

Think about the last time you threw out an overripe banana, a handful of wilting greens, or the pulp left over after pressing juice. Now multiply that by every farm, food factory, and supermarket across Europe.

The number is hard to sit with. According to Eurostat, the EU wastes over 59 million tonnes of food every year, worth an estimated 132 billion euros. And that does not even count what disappears at the farm gate before it reaches anyone.

The default response for most of this waste has been the same for decades: burn it, compost it, or run it through a biogas plant. These are not bad options. But in a world where animal protein demand is set to climb 52% by 2050 and Europe imports nearly 89% of its phosphate fertilizers from politically unstable regions, they start to feel like we are leaving a lot on the table.

What is the circular economy? The circular economy is an economic model that eliminates waste by keeping resources in use for as long as possible – extracting maximum value from them, then recovering and regenerating products and materials at the end of their service life. Applied to food, it means treating organic residues not as waste to dispose of, but as inputs for new production cycles.

What if this waste was never really waste at all?

Where does Europe’s food waste actually come from?

Most people picture overflowing kitchen bins when they hear “food waste.” The reality is messier than that. The EU’s waste problem is spread across the entire food supply chain, from field to factory to fork.

Here is the breakdown, according to the European Environment Agency:

• Households are the biggest culprit, responsible for around 55% of total food waste
• Food processing and manufacturing adds roughly 24 kg per person every year
• Farms themselves contribute about 10 kg per person per year before food even leaves the field

But the less-talked-about side of the story is agricultural side streams. The stuff that does not make headlines: the peelings and pomace from fruit and vegetable processing, the manure and slurry from livestock farms, the whey left over from making cheese, the husks and bran from grain milling. Tonne after tonne, day after day, at every farm and food facility across the continent.

Zoom out to the global picture and it gets even harder to ignore. The UN Environment Programme’s Food Waste Index 2024 puts global food waste at approximately 1.05 billion tonnes in 2022 alone. That is around 19% of all food produced for human consumption. Put it another way: if food waste were its own country, it would be the third largest emitter of greenhouse gases on the planet, behind only the USA and China.

Why burning food waste is not a Circular Economy solution

Incineration turns a resource problem into a loss problem. You get energy once, and then everything else is gone forever.

For decades, sending organic waste to incineration or biogas plants has felt like a reasonable solution. You get energy out of it. That counts for something. But what gets quietly ignored is everything that goes in and never comes back out.

Take phosphorus. It is a finite, non-renewable mineral with no synthetic substitute, and it is essential for growing food. Europe imports nearly all of it, much of it from geopolitically fragile regions. When phosphorus-rich organic waste goes into an incinerator, it is not recycled. It is destroyed permanently. There is no getting it back.

The same is true for the proteins, fats, and micronutrients locked inside food side streams. We spent land, water, and energy producing them. Then we burn them and call it waste management.

The circular economy framework asks a different question entirely. Not: how do we get rid of this as cheaply as possible? But: how do we get the most value back out of it? That one shift in thinking changes everything that follows.

What is insect bioconversion, and how does it work?

It sounds niche. The science behind it is anything but.

One of the most compelling developments in circular economy research over the past five years is surprisingly low-tech: insects. Specifically the black soldier fly, a species that turns out to be extraordinarily efficient at converting organic waste into three useful things at once.

Feed it your food residues and you get back:

• High-quality protein, suitable for animal feed, aquaculture, and pet food
• Insect fat, which can replace conventional oils in industrial and feed applications
• Frass, an exceptionally nutrient-rich organic fertilizer that puts phosphorus straight back into the soil where it belongs

The climate comparison is striking. Life-cycle assessments put black soldier fly larvae at roughly 1.5 kg of CO2-equivalent per kilogram of protein produced. Beef sits at around 10 kg for the same amount. Research published in Frontiers in Sustainability found that using larvae to process food and agricultural residues can cut methane emissions by up to 80% compared to standard waste disposal.

What makes this practical rather than theoretical is the flexibility. The larvae are genuinely not picky. Fruit peelings, grain residues, wine pomace, dairy surpluses, poultry litter: it all works as feedstock. If one source dips seasonally, another fills the gap.

And the results hold up at scale. A Dutch study documented around 20,000 tonnes of insect protein produced annually from food waste in the Netherlands alone. A case study in Uganda found that applying BSF frass as fertilizer increased maize yields by 30%. These are not projections. They are documented outcomes.

Is insect protein legal in the EU? What the regulations say

For a long time, regulation was the biggest bottleneck. Insect-derived proteins existed. The market for them existed. But the legal framework to actually use them in mainstream feed was not there.

That started to change in 2017, when the EU authorized insect proteins in aquaculture feed. Then in 2021, the authorization extended to poultry and pig feeds. That second step in particular unlocked a much larger market almost overnight.

On top of that, the EU has now introduced binding food waste reduction targets, requiring member states to cut food processing waste by 10% and retail and household waste by 30%, both by 2030. For food producers and processors, that means rising pressure to find better uses for their organic residues, and rising costs if they do not.

The market is moving accordingly. IPIFF estimates that EU production capacity could reach up to 1 million tonnes of insect meal annually by 2030. The global insect feed market is projected to grow at around 22% per year, reaching 3.6 billion dollars by 2031. The regulatory window is open. The commercial window is opening with it.

Austria’s food waste problem – and its Circular Economy opportunity

Austria is one of the most organically farmed countries in the world. It is also sitting on some of the largest untapped organic waste streams in Europe.

Austria leads the EU in organic farmland. As of 2023, nearly 27.4% of all agricultural land is organically managed, already surpassing the EU’s own 25% target for 2030. That is something to be genuinely proud of. But it also means Austria generates enormous volumes of agricultural side streams, from the valleys to the Alps, every single day.

Here is where it gets interesting. The industries generating the most organic waste in Austria are not factories in the distance. They are the backbone of the country’s rural economy:

• Dairy farming – around 22,700 Austrian dairy farmers produce 3.6 million tonnes of raw milk annually. Cheese production, Austria’s largest dairy export, leaves behind significant volumes of whey surplus, a protein-rich stream that is costly to dispose of and ideal as circular feedstock.
• Cattle farming – Austria has approximately 1.835 million cattle, most on small family farms across mountainous regions. Each animal produces manure daily, and with over 75,500 livestock farms in the country, that adds up to an enormous continuous residue stream.
• Fruit and vegetable processing – Austria is an agricultural country with strong regional fruit and wine production. Apple pomace alone accounts for 25% of fruit weight after pressing, and grape marc from wine regions like Burgenland and Styria adds millions more tonnes per harvest.
• Food industry and catering – Austria generates approximately 1 billion euros worth of avoidable food waste every year, with agriculture contributing around 30% of the total. That is not just an environmental issue. It is a cost that farms and processors are actively looking to reduce.

What makes Austria particularly well-suited for circular systems is exactly what defines its agriculture: small-scale, family-run, geographically spread across regions. A modular approach that processes residues on-site, at the farm or facility where they are generated, fits this landscape far better than centralised industrial solutions ever could. It does not need to ship waste across the country. It closes the loop right where it starts.

Why Circular Economy startups are attracting impact investors

Here is what makes this space genuinely compelling from an investment perspective, beyond the environmental story.

Companies building circular systems around organic waste are not selling a product into an existing market. They are solving two problems at the same time:

• They give agricultural and food industry clients a cheaper, better alternative to waste disposal
• They produce high-value outputs, protein, fat, fertilizer, that replace expensive imported materials

That dual model is hard to replicate and creates a natural defensibility. It also means the business case does not depend on a single price signal. When disposal costs rise, the value proposition strengthens. When feed prices rise, so does the value of the output.

At Invesdor, we look for companies where the impact case and the financial case are telling the same story. The circular economy space around organic waste is one of the clearest examples of that overlap we see right now. The science is solid. The regulation is moving in the right direction. And the market need is not going anywhere.

The bottom line

A banana peel is not waste. Fruit pomace is not waste. Poultry litter is not waste. They are packages of protein, fat, and minerals that took land, water, energy, and time to produce.

Sending them to an incinerator destroys all of that embedded value in one go. The circular economy is not asking us to be less efficient. It is asking us to finally be honest about what efficiency actually means.

In a world where protein demand is climbing, fertilizer imports are a geopolitical risk, and food waste is costing Europe over 132 billion euros a year, the most efficient thing we can do is stop treating our most valuable residues like garbage.

The technology is here. The regulation is catching up. The only question left is whether the capital will follow.

Frequently Asked Questions

What is insect bioconversion?

Insect bioconversion is the process of using insect larvae – most commonly the black soldier fly (Hermetia illucens) – to convert organic waste into high-value outputs including protein meal, fat, and frass fertilizer. The larvae consume food residues and agricultural side streams, and are then harvested to produce feed ingredients that replace conventionally produced alternatives.

Is insect protein approved for use in animal feed in the EU?

Yes. The EU authorised insect-derived proteins in aquaculture feed in 2017 (Regulation EU 2017/893) and extended this to poultry and pig feeds in 2021 (Regulation EU 2021/1372). Insect protein is not currently approved for use in ruminant feed within the EU.

How much CO₂ does insect protein produce compared to beef?

Life-cycle assessments put black soldier fly larvae at approximately 1.5 kg of CO₂-equivalent per kilogram of protein produced. Beef sits at around 10 kg for the same amount – making insect protein roughly 6 to 7 times less carbon-intensive.

How much food waste does Austria produce each year?

Austria generates approximately 1 million tonnes of food waste per year, equivalent to around 134 kg per person. Roughly 58% of this comes from private households. Agriculture contributes around 30% of avoidable food waste, estimated at close to €1 billion in value annually. Austria’s circular material use rate currently stands at 14.3%, against an EU target of 18% by 2030.

What is frass and why does it matter?

Frass is the organic byproduct of insect rearing – a mixture of insect excrement, shed exoskeletons, and residual feed material. It is exceptionally nutrient-rich and acts as an organic fertilizer, returning phosphorus and nitrogen to the soil. Field trials have shown BSF frass can increase crop yields by up to 30% compared to conventional fertilization, making it a key output of circular insect farming systems.

The post Circular Economy: How food waste is becoming protein first appeared on Invesdor - Blog.

Does it quietly sit on a balance sheet or does it build solar sites, accelerate medical innovation and create measurable change?

That is the core question behind impact investing.

At Invesdor, we see every day how intentionally deployed capital contributes to real-world progress. When investors choose where their money goes, they enable financially viable companies to scale solutions that address concrete social and environmental challenges.

Impact and financial returns are not opposites. When done right, they reinforce each other.

Impact investing in practice   

Impact investing focuses on directing capital towards companies that generate positive social or environmental outcomes alongside financial returns. Rather than treating impact as a secondary effect, impact investing integrates measurable impact directly into business strategy and growth.

Across Europe and beyond, more investors are actively seeking opportunities to align their capital with long term sustainability and real world outcomes.

Impact starts with where your capital goes

Impact does not happen automatically. In impact investing, it is the result of deliberate investment decisions. Investors allocate capital to businesses that address real world challenges and are designed to scale, often at stages where traditional bank financing is limited.

Across sectors such as energy, healthcare and consumer goods, impact investing supports companies at different stages of growth and market expansion.

Examples illustrate what this looks like in practice.

Clean energy that strengthens local economies 

In Uganda and Rwanda, power outages are part of everyday life for many small businesses. An interrupted cold chain can spoil an entire delivery. An hour of downtime means lost revenue. 

Sawa Energy faced the challenge of expanding renewable energy where it is urgently needed. Between 2022 and 2023, Sawa Energy raised €1,399,734 via Invesdor. This funding played a catalytic role by unlocking additional financing and accelerating the rollout of renewable energy infrastructure in Uganda and Rwanda.

The funding enabled:

• the commissioning of 54 solar sites 
• 3.6 MWp of installed solar capacity 
• 1 MWh of battery storage 
• an estimated CO₂ reduction of around 2,400 tons 

For small and medium sized businesses, this translates into fewer power outages, lower energy costs and greater operational reliability. In regions where grid instability is common, reliable electricity is not a luxury but a foundation for economic growth. 

Beyond infrastructure deployment, Sawa Energy expanded its operations and grew its core team from 3 to 17 permanent employees. This strengthened local expertise and created a solid foundation for long term impact and further scale. 

This is investor capital turning into climate action and economic resilience on the ground. 

Medical innovation that changes everyday life 

In the Netherlands, patients are now testing a wearable artificial kidney at home for the first time. The NeoKidney is developed by Nextkidney, in collaboration with UMC Utrecht and the Nierstichting.

For people with kidney failure, dialysis often means long hospital sessions several times per week, placing a heavy burden on daily life. The NeoKidney aims to make dialysis portable, allowing treatment at home or while travelling.

The ongoing clinical study focuses on safety, effectiveness, ease of use and the impact on daily routines and quality of life. As lead researcher Karin Gerritsen explains, dialysis is life saving but also demanding. A wearable artificial kidney can give patients more freedom and autonomy.

This kind of progress is only possible when innovation receives the funding it needs to move from concept to real world testing. In 2023 alone, more than 1.200 investors contributed over €4 million via Invesdor, supporting impact driven healthcare solutions like this one.

Here, impact is felt directly by people in their everyday lives.

Nordic health technology gaining international attention

Koite Healthcare was also facing a decisive step. With Lumoral, the company developed a technology that treats gum inflammation at home. It specifically targets bacterial biofilm, does not use chemicals, and protects the natural oral microbiome. 

A medical device developed by Koite Healthcare was recently featured on German national television on ARD’s Morgenmagazin on 27 January 2026, reaching millions of viewers. During a segment on oral health, Professor Werner Birglechner, one of Germany’s leading dental educators, highlighted Lumoral as a breakthrough in at home gingivitis care.

The technology addresses the root cause of inflammation by disrupting bacterial biofilm and significantly reducing harmful bacteria, without chemicals and without damaging the beneficial oral microbiome.

Expert validation of this kind on national television is rare. It underscores strong clinical credibility and highlights growing international momentum in Europe’s largest healthcare market.

What these impact investing examples show 

While operating in different sectors and regions, these examples illustrate how impact investing works in practice. They address clearly defined challenges, focus on scalability and make their social and environmental impact measurable.

From renewable energy projects in East Africa to medical innovation across Europe, impact investing channels capital to solutions that might otherwise struggle to secure growth financing, particularly in critical development stages.

Impact does not happen by accident. It is the result of deliberate allocation decisions, transparency and engaged investors.

So do you really make a difference as an investor?

Yes, when you invest intentionally through impact investing.

The stories of Sawa Energy, Nextkidney and Koite Healthcare demonstrate how investments via Invesdor enable tangible projects and innovations, create measurable social and environmental impact and support mission driven companies in scaling sustainably.

Impact is not a side effect. It is the result of conscious choices, transparency and engaged investors.

Investing with purpose

As an investor, you are not just providing capital. You are enabling solutions.

Whether it is clean energy for businesses in East Africa or greater freedom for dialysis patients in Europe, your investment can bridge the gap between promising ideas and real world change.

For investors interested in European impact investing opportunities with measurable outcomes, Invesdor provides transparent access to curated projects across multiple sectors and regions.

That is what making a difference truly looks like.

Discover new impact investment opportunities
Subscribe to receive curated updates on impact investing, selected projects, and developments across energy, healthcare, and sustainable consumer goods.

The post Impact Investing: Do I really make a difference as an Investor? first appeared on Invesdor - Blog.

When energy supply suddenly becomes fragile

And suddenly the power is out. Countless households must be evacuated. People spend the night in poorly heated gyms—including those who require special care. This happened in January 2026 in Germany’s capital, Berlin. 

For a long time, energy in Europe was considered a given. But events of recent years—from geopolitical tensions and extreme weather to local blackouts like in Berlin—have shown how vulnerable even highly developed energy systems can be. 

These experiences make one thing clear: energy security is not just a national issue. It is a European task—technically, economically, and politically. And there are solutions if we think beyond borders. 

Europe’s energy transition: from a technology issue to an infrastructure challenge  

Europe is pursuing ambitious goals in the expansion of renewable energy. Solar and wind power are being massively scaled up in nearly all member states. Solar energy has become a central pillar of electricity generation in many European countries. From Southern Europe to Scandinavia, installed capacity is growing—on residential rooftops, in industrial facilities, and in large-scale solar parks. Wind power complements this generation, especially in coastal areas and offshore. (Quelle: Solarpower ) 
 

Solar and wind energy are becoming more important 

• Solar will cover around 13.4% of EU 
  electricity demand in 2025 (2023: 9.7%). 

• In June 2025, solar became the EU’s largest 
  electricity source for the first time.  

• Wind and solar together now supply over 
  30% of electricity, increasingly displacing 
  fossil fuels.  
  
  (Sources: Solarpowereurope, Wikipedia )  

For Europa this means: 

• high scalability 
• regional value creation 
• reduced dependency on energy imports 

Manufacturers of solar panels and wind components are an essential part of the system. They drive technological innovation, expand production capacity, and ensure stable supply chains—all prerequisites for the continued expansion of renewables in Europe. 

But with this growth, the energy system itself is changing. Traditional power plants delivered electricity on demand; renewables are weather-dependent. Consumption follows different patterns: industry, households, mobility and digitalization create demand peaks at specific times of day. 

This leads to imbalances. And this is where it becomes clear that the energy transition is not just about technology—it’s about infrastructure. It’s about the interaction between generation, storage, grids and intelligent control—real, investable structures. 

Energy generation in Europe: solar and wind as the foundation

Solar and wind power form the foundation of renewable energy generation in Europe. Both technologies are mature, scalable and competitive in the long term. At the same time, Europe is developing new production capacities for solar panels, inverters and wind components to stabilize supply chains and reduce dependencies. 

For investors, projects in this area are attractive when they are well integrated into regional energy structures. Key factors include site quality, grid connection, operational concepts and long-term marketing models. Pure generation without storage or flexible marketing is increasingly hitting economic limits. 
 

Case study: scalable solar energy (financed via Invesdor)

A good example of system-oriented solar energy is  Der Solarteur. The company plans and installs photovoltaic systems, as well as heating and battery systems, for the housing sector and for commercial and industrial customers. 

Since its founding in 2021, Der Solateur has completed over 2,800 installations. It addresses a key bottleneck of the energy transition: the need for scalable, qualityassured solutions to quickly decarbonize existing buildings, especially for large housing providers. 

Digitalized processes, reliable supply chains and experienced installation teams allow the execution of large-scale projects—a clear advantage in a fragmented market. A framework agreement with one of Europe’s largest housing companies highlights the company’s strategic positioning. 

Remarkable:
The project sparked strong interest among investors: €1.1 million was funded in less than 48 hours.

The market shows: generation remains the foundation—but it’s only the first step.   

This is where sustainable investment projects come in, financing the construction and operation of such storage facilities. 
 

Battery storage: the key to Europe’s energy security

Renewable energy is generated when the sun shines, the wind blows, or water flows. It depends on the weather and, unlike fossil fuels, cannot be easily controlled by humans. So how can we still use these forms of energy reliably and make them predictable? Battery storage fills a crucial gap in Europe’s energy system. It absorbs electricity when supply is abundant and releases it when demand and prices rise. This makes renewables more predictable and economically viable. 

Technically, battery storage systems perform several tasks: 

• stabilizing power grids   
  
• balancing load peaks 
  
• reducing curtailment of generation plants .  

Europe’s battery storage market is growing rapidly. According to the European Market Outlook for Battery Storage 2025–2029 installed capacity is set to grow significantly in the coming years—driven by rising demand for flexibility.

Large-scale storage, neighborhood solutions, and hybrid solar-storage projects are developing into infrastructure investments. They help make national grids more resilient to unexpected events.

For households, businesses and entire neighborhoods, storage solutions can increase independence from central grids.

Case study: battery storage for system stabilization (financed via Invesdor) 

Two examples of grid-supporting Battery Energy Storage Systems (BESS) on Invesdor 
are  BESS Remscheid Luckhausen and BESS Wehr. Both use battery systems to store surplus  electricity from renewable sources and feed it back into the grid later. 

These systems balance load peaks, reduce curtailment of solar and wind power, and contribute to grid stability. They exemplify how battery storage becomes a core part of energy infrastructure—both technically and economically. Such projects also open up new revenue potential through flexible electricity trading and increase the predictability of renewable energy.  
 
For investors this means: storage is no longer a supplement—it’s a key value driver. 

Energy infrastructure: the often underestimated investment factor

Between generation and consumption lies infrastructure. Grids, substations, connections, installations and maintenance ensure that renewable electricity actually reaches where it’s needed.

This area is highly relevant for sustainable investment. Infrastructure projects stand out through long-term use, predictable income, and high system relevance. They form the backbone of the energy transition and are being promoted and expanded at the European level.

Infrastructure may be less visible than solar panels or wind turbines – but it’s often decisive for the system’s overall stability and profitability. 

Case study: wind power as integrated energy infrastructure (financed via Invesdor) 

Wind power creates the most value when it is operated continuously, at scale and integrated into the grid. Projects like Windpark Fryslân and Westermeerwind on Invesdor do just that. 

Both parks feed significant amounts of renewable electricity into the grid and contribute reliably to Europe’s energy supply. What matters is not only the generation capacity but the integration into existing grid infrastructure. As long-term infrastructure projects, these wind farms combine renewable electricity production with energy security and regional value creation.

Digital control: efficiency that drives returns 

As energy systems become more decentralized, digital control grows in importance. Smart grids and energy management systems coordinate generation, storage and consumption in real time. They determine when electricity is stored, used, or traded.

Digital solutions are a key factor in the profitability of modern energy projects. They increase income predictability, reduce losses, and allow flexible responses to market prices. Technology and software are closely tied to stable returns. 

Investing in renewable energy in Europe: projects with substance 

This systemic perspective opens up new opportunities for investors. Potential lies not just in individual technologies but throughout the entire value chain:

• Generation
• Storage
• Infrastructure
• control 

Europe is committed to long-term regulation, clear climate goals, and continuous energy infrastructure expansion. This creates planning security—a crucial factor for sustainable investment.

Renewables in Europe are no longer just a climate issue. They’re part of a structural transformation of the energy supply. Those who invest are not betting on isolated products but on a system built on collaboration, scalability and long-term stability. 

Renewable energy in Europe: sustainable investment with impact 

Transforming Europe’s energy system requires significant investment. Generation, storage, grids and digital control must grow in parallel to maintain system stability.  

“Renewable energy investments in Europe are no longer just about climate impact — they are about resilience, security and economic sovereignty. Solar, wind, storage and infrastructure only create real value when they are understood as one interconnected system. Investing in this system means strengthening Europe’s energy independence, stabilising supply in times of crisis, and building long-term, infrastructure-backed returns for investors. That combination of impact and resilience is what makes renewable energy such a compelling investment today.” (Christopher Grätz, CEO Invesdor Group)

Those who participate in these projects invest in infrastructure with societal relevance. This is not about short-term trends but about assets with long-term value and impact. 

Sustainable energy projects combine economic rationale with the creation of a future-proof energy system for Europe. 

Interested in learning more about investment opportunities in the European energy sector? Find in-depth information and current projects in the field of renewable energy here: 

The post Investing in renewable energy first appeared on Invesdor - Blog.

1. Keep a Cool Head 

In economically stormy weather, it’s tempting to react emotionally. However, such reactions are not always beneficial. Market downturns are unpleasant but part of the investing journey. Those who act out of fear often miss the recovery that follows shortly after. In times like these, calmness and patience are your greatest allies. 

2. Diversify – stay close to home

Diversification is essential in any market, but especially when volatility is high. By spreading your investments across different sectors, regions, and types of companies, you limit risk and increase your chance of stable returns. Don’t put all your eggs in one basket — build a well-balanced, resilient portfolio. But diversification doesn’t always mean going global. In fact, focusing on stable, locally rooted companies can be a smart move — especially now. 

That’s why Invesdor offers direct investments in Northern European companies — businesses that are not only based here but also generate most of their revenue within the region. These are companies you can understand, support, and grow with. Unlike many stock-listed multinationals with high exposure to global uncertainty, our companies are anchored in local economies and have a strong regional focus. 

What exactly does investment diversification mean?
The article “Investment Diversification Made Simple” explores key principles in more detail, provides concrete examples, and offers helpful context.

3. Look Beyond the Stock Market

One of the advantages of direct investing is the ability to invest in non-listed, local companies — businesses that are not subject to daily stock market fluctuations and short-term investor sentiment. These companies, often rooted in local European communities, tend to have a long-term focus and sustainable growth ambitions. By supporting them, you’re investing in the strength and resilience of the (Northern) European economy. 

4. Invest in Sustainable Companies

Sustainable businesses — those focused not just on profit but also on people and the planet — often prove more resilient in uncertain times. These companies build for the long term, maintain strong relationships with stakeholders, and take a future-focused approach. Especially now, it’s worthwhile to support businesses that aim to make the world a better place. 

In Conclusion: Think Long-Term 

Economic shocks are often temporary. A well-diversified portfolio, on the other hand, is built to last. Don’t get caught up in the noise of the moment. History shows that markets tend to recover after periods of turmoil. At Invesdor, we help you invest directly in companies that matter — close to home, with a long-term vision. Stay calm, stay close, and invest wisely. 

The post Direct investing in turbulent times: stay calm and diversify  first appeared on Invesdor - Blog.